Related Experiment Video
Updated: Aug 24, 2025

05:45
Author Spotlight: Integrating Organoid Models with Single-Cell and Spatial Transcriptomics Technologies
Published on: March 29, 2024
2.5K
Development of bioinformatics and multi-omics analyses in organoids
Doyeon Ha1, JungHo Kong1, Donghyo Kim1
1Department of Life Sciences, Pohang University of Science and Technology, Pohang 37673, Korea.
BMB Reports
|October 26, 2022
Summary
Patient-derived organoid models offer a faithful recapitulation of human tissues for disease research. Computational methods are advancing to systematically analyze organoid experimental results, improving disease understanding and therapeutic discovery.
Area of Science:
- Biomedical research
- Translational medicine
- Organoid technology
Background:
- Pre-clinical models are essential for understanding disease mechanisms and progression.
- Patient-derived organoids (PDOs) are emerging as powerful tools that mimic in vivo human tissues.
- PDOs hold promise for advancing disease development studies and identifying therapeutic strategies.
Approach:
- This review summarizes recent advancements in organoid model development for recapitulating human diseases.
- It also highlights computational methodologies for analyzing organoid experimental data.
- The focus is on integrating organoid technology with computational analysis for enhanced research capabilities.
Key Points:
- Organoid models provide a more accurate representation of human physiology compared to traditional pre-clinical models.
- Technological progress in organoid development is rapidly expanding their applications.
- Computational tools are becoming indispensable for managing and interpreting the complex data generated from organoid studies.
Conclusions:
- The synergy between advanced organoid models and sophisticated computational analysis is crucial for future biomedical research.
- These integrated approaches accelerate the understanding of human diseases and the development of targeted therapies.
- Continued innovation in both organoid technology and data analysis will drive significant breakthroughs in medicine.

